To prohibit any Federal law from making the manufacturer of a COVID-19 vaccine immune from suit or liability, or limiting the liability of such a manufacturer, with respect to claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a COVID-19 vaccine, and for other purposes.

2/28/2025, 9:06 AM
Congress
119

Number
HR - 1432

Introduced on
2025-02-18

# Amendments
0

Sponsors
Chip Roy

Cosponsors
+5

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Referred to the House Committee on the Judiciary.
Bill 119 HR 1432, also known as the "COVID-19 Vaccine Manufacturer Accountability Act," aims to prevent any Federal law from granting immunity to manufacturers of COVID-19 vaccines from lawsuits or liability. The bill specifically prohibits limitations on the liability of vaccine manufacturers in cases where individuals experience loss or harm as a result of receiving or using a COVID-19 vaccine.

The purpose of this legislation is to ensure that individuals who may suffer adverse effects from a COVID-19 vaccine have the ability to seek legal recourse against the manufacturer. By preventing immunity or limitations on liability, the bill aims to hold vaccine manufacturers accountable for any harm caused by their products.

In addition to addressing liability issues, the bill also includes provisions for other purposes related to COVID-19 vaccine administration and use. This legislation is significant in ensuring that individuals have the ability to seek justice in cases where they experience harm from a COVID-19 vaccine, without being hindered by legal protections granted to manufacturers.
Alternative Names
Official Title as IntroducedTo prohibit any Federal law from making the manufacturer of a COVID-19 vaccine immune from suit or liability, or limiting the liability of such a manufacturer, with respect to claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a COVID-19 vaccine, and for other purposes.

Comments

Recent Activity

Latest Action2/18/2025
Referred to the House Committee on the Judiciary.